Cancer Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 844 studies associated with Cancer.
Here is a small sampling of Cancer studies by title:
- Hepatoprotective Effect Assessment of C-Phycocyanin on Hepatocellular Carcinoma Rat Model by Using Photoacoustic Spectroscopy
- The Association Between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients
- Chemical compounds, anti-tumor and anti-neuropathic pain effect of hemp essential oil in vivo
- Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders
- The Association between Oxaliplatin-Induced Peripheral Neuropathy, Sociodemographic, and Clinical Characteristics with Falls in Older Adults with Colorectal Cancer
Components of the Cancer Research Dashboard
- Dosing information available for Cancer
- Chemotype guidance for treating Cancer with cannabis
- Synopsis of cannabis research for Cancer
- Individual study details for Cancer
Ready to become a subscriber? Go to our PRICING page.
Cancer Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 844 studies associated with Cancer.
Here is a small sampling of Cancer studies by title:
- Hepatoprotective Effect Assessment of C-Phycocyanin on Hepatocellular Carcinoma Rat Model by Using Photoacoustic Spectroscopy
- The Association Between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients
- Chemical compounds, anti-tumor and anti-neuropathic pain effect of hemp essential oil in vivo
- Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders
- The Association between Oxaliplatin-Induced Peripheral Neuropathy, Sociodemographic, and Clinical Characteristics with Falls in Older Adults with Colorectal Cancer
Components of the Cancer Research Dashboard
- Dosing information available for Cancer
- Chemotype guidance for treating Cancer with cannabis
- Synopsis of cannabis research for Cancer
- Individual study details for Cancer
Ready to become a subscriber? Go to our PRICING page.
Select New Condition
Overview - Cancer
Description of Cancer
Within the orthodox medicine model, cancer (malignant neoplasm) starts with the corruption of genetic material (a mutation) inside a normal and otherwise healthy cell.
Common, known risk factors that can bring about such genetic alterations include family history, consumption of alcohol and tobacco, obesity, occupational carcinogen exposure, and certain viruses like HPV.
Evidence suggests that cellular cancer may frequently occur in everybody, but the body's proper immune defenses can typically cure these threats. However, when the body's overall health is weakened, the growth of mutations may overwhelm the body's capacity to heal them, and cancer can take over.
One theory of cancer posits that cellular corruption begins with exposure to a carcinogen (cancer-producing toxin). The now-corrupted cell begins to divide, but instead of generating healthy new cells, it produces new cancerous cells.
Symptoms vary greatly, depending on where the cancer is located and how far it has progressed. Staging is commonly used to determine the extent of disease and communicate that to the patient and other providers.
Orthodox treatment is usually limited to chemotherapy, surgery, and radiation.
Alternative and integrative medicine treatments typically include mind-body approaches, dietary changes, herbs and nutraceuticals, IV mistletoe and vitamin C, Reiki, and traditional Chinese medicine (TCM). These practitioners may also incorporate cannabis among these potential therapies.
Disease Classification
Condition: CancerDisease Family: Cancer
Organ System: Cardiovascular System, Digestive System, Endocrine System, Immune System, Integumentary System, Muscular System, Nervous System, Reproductive System, Respiratory System, Skeletal System, Urinary System
ICD-10 Chapter: Neoplasms
ICD-10 Code: C80
Cancer Symptoms:
Mutation, abnormal cell growth (e.g., lump, tumor, mass, ulceration), spreading to other areas of body (metastasis), unexplained weight loss, pain, fatigue, low appetite, fever, chills, malaise, night sweatsAlso known as:
Disseminated malignant neoplasmDrug Interactions
THC Interaction with Pharmaceutical Drugs
- Tetrahydrocannabinol (THC) can enhance the effects of drugs that cause sedation and depress the central nervous system, such as benzodiazepines, barbiturates, and alcohol.
- THC is metabolized by an inhibitor of several enzymatic liver pathways referred to as cytochrome P450 (aka CYP450). There are more than 50 enzymes belonging to this enzyme family, several of which are responsible for the breakdown of common drugs such as antidepressants (e.g., amitriptyline, doxepin, fluvoxamine), antipsychotics (haloperidol, clozapine, Stelazine), beta-blockers (e.g., propranolol), bronchodilators (e.g., theophylline), or blood thinners (e.g., warfarin). Thus, patients taking these medication classes may find that THC increases the concentration and effects of these drugs and the impact duration.
- Clinical observation (not yet confirmed by clinical trials) suggests no likely interactions with other pharmaceuticals at a total daily dose of up to 20mg THC.
If you are interested in the interaction potential of specific pharmaceuticals with THC, consider visiting these free drug interaction checkers: Drugs.com or DrugBank Online.
CBD Interaction with Pharmaceutical Drugs
- Cannabidiol (CBD) may alter the action of metabolic enzymes (specific drug-transport mechanisms) and alter interactions with other drugs, some of which may produce therapeutic or adverse effects. For instance, CBD interacts with the enzyme cytochrome P450 3A4 and cytochrome P450 2C19, increasing the bioavailability of anti-epileptic drugs such as clobazam (a benzodiazepine). This makes it possible to achieve the same results at significantly lower dosages, reducing treatment costs and risks of adverse effects.
- Groups of drugs affected include anti-epileptics, psychiatric drugs, and drugs affecting metabolic enzymes.
- Clinical observations (not yet confirmed by clinical trials) suggest no likely interactions with other pharmaceuticals at a total daily dose of up to 100mg CBD.
If you are interested in the interaction potential of specific pharmaceuticals with CBD, consider visiting these free drug interaction checkers: Drugs.com or DrugBank Online.
THC/CBD Interaction with Pharmaceutical Drugs
In general, when using cannabinoid-based therapeutics that contain both THC and CBD consider the ratio between them and weigh the relevant information displayed in the individual THC and CBD Drug Interaction windows accordingly.
If you are interested in the interaction potential of specific pharmaceuticals with both primary cannabinoids and THC/CBD, consider visiting these free drug interaction checkers: Drugs.com or DrugBank Online.
Concerns about Cannabis and Cancer-related Immunotherapies:
Some recent clinical observational studies have suggested that the co-administration of cannabinoid-based therapeutics and immunotherapy or immune checkpoint inhibitors in the treatment of certain types of cancer has been associated with worse overall survival rates (T. Taha et al., 2019; A. Biedny et al., 2020; G. Bar-Sela et al., 2020).
However, other studies have suggested that the co-commitment use of immune checkpoint inhibitors and cannabis-induced no such deleterious effects. More specifically, one trial was conducted on animals resulting in data suggesting that cannabis did not negatively affect the properties of immune checkpoint inhibitors (B. Waissengrin et al., 2023). The same authors compared the previous study results with findings from a cohort of 201 patients with metastatic non-small cell lung cancer who received treatment with monotherapy pembrolizumab as a first-line treatment and adjunct cannabis to treat mainly pain and loss of appetite. Their time to tumor progression was 6.1 versus 5.6 months, and overall survival differed between 54.9 versus 23.6 months in cannabis-naïve patients and cannabis-using patients, respectively. However, while numerically different, the authors write that these differences were not statistically significant, leading them to suggest that “These data provide reassurance regarding the absence of a deleterious effect of cannabis in this clinical setting.”
Dosing Considerations
THC Dosage Considerations
- THC micro dose: 0.1 mg to 0.4 mg
- THC low dose: 0.5 mg to 5 mg
- THC medium dose: 6 mg to 20 mg
- THC high dose: 21 mg to 50+ mg
CBD Dosage Considerations
- CBD low dose: 0.4 mg to 19 mg
- CBD medium dose: 20 mg to 99 mg
- CBD high dose: 100 mg to 800+ mg (upper limits tested ~1,500mg)
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
